Titan Pharmaceuticals, Inc. (TTNP) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
02K5K8K10K12K15K18K20KQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Margin (%)

Gross MarginOperating MarginNet Income Margin
0815223038455260Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Operating Expenses

General And Administrative Expenses
0100K200K300K400K500K600K700K800KQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

EBITDA

EBITDA
-1M-875K-750K-625K-500K-375K-250K-125K1Q4 2024Q1 2025Q2 2025Q3 2025

EPS

Revenue Variation (%)

Revenue Variation
-200-175-150-125-100-74-49-241Q1 2025

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
0815223038455260Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Revenue YoY Variation (%)

Revenue YoY Variation
-200-175-150-125-100-74-49-241Q4 2024

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
0124568910Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Price-to-Earning Ratio

P/E Ratio
-20-17-15-12-10-7-4-21Q4 2024Q1 2025Q2 2025Q3 2025

Income Breakdown

Per Share Metrics

Expense Ratios

💰 Cash Flow Statement

Operating Cash Flow

Capex To RevenueStock Based Compensation To Revenue
000001111Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Free Cash Flow

Cash Flow to Debt Ratio

Cash At End Of Period
0500K1M2M2M2M3M4M4MQ4 2024Q1 2025Q2 2025Q3 2025
🏦 Balance Sheet
📈 Key Metrics